Cumberland Pharmaceuticals Inc.
209 10th Avenue
Suite 332
Nashville
Tennessee
37203
United States
Tel: 615-255-0068
Fax: 615-255-0094
Website: http://www.cumberlandpharma.com/
Email: mail@cumberlandpharma.com
261 articles about Cumberland Pharmaceuticals Inc.
-
Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote(R) Supplemental New Drug Application; New PDUFA Date in December 2010
8/23/2010
-
Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
8/17/2010
-
Cumberland Pharmaceuticals to Present at the Bank of America Merrill Lynch Specialty Pharmaceuticals Conference in Southampton, New York on August 13, 2010
8/3/2010
-
Cumberland Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 16, 2010
7/28/2010
-
Cumberland Pharmaceuticals to Present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference in New York
7/26/2010
-
Cumberland Pharmaceuticals's Caldolor(R) (Ibuprofen) Injection Shown to Significantly Reduce Fever in Malaria Patients in Newly Published Clinical Trial
7/12/2010
-
Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
6/4/2010
-
Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
5/21/2010
-
Cumberland Pharmaceuticals Reports First Quarter 2010 Earnings
5/14/2010
-
Cumberland Pharmaceuticals Acetadote(R) Approved in Australia for Treatment of Acetaminophen Poisoning
5/11/2010
-
Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
5/3/2010
-
Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
4/28/2010
-
Cumberland Pharmaceuticals Adds Three to Board With New Elections at Annual Shareholder Meeting
4/20/2010
-
Cumberland Pharmaceuticals: Acetadote(R) Supplemental New Drug Application for Acute Liver Failure Submitted to FDA
3/30/2010
-
Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
3/10/2010
-
Cumberland Pharmaceuticals: New Data from Caldolor(R) Study in Burn Patients to be Presented at 42nd Annual Meeting of The American Burn Association
3/2/2010
-
Cumberland Pharmaceuticals to Announce Year-End 2009 Financial Results on March 10, 2010
2/25/2010
-
Cumberland Pharmaceuticals: New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting - - Study Results Demonstrate Effect of More Rapid Infusion Time for Caldolor
12/3/2009
-
Cumberland Pharmaceuticals: Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems
12/1/2009
-
Cumberland Pharmaceuticals: Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients
11/23/2009